These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1676940)

  • 1. The inhibitory effect of bevantolol on the accumulation of non-esterified fatty acids during ischaemia in the dog heart in situ.
    Miura I; Nasa Y; Ichihara K; Abiko Y
    Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):259-62. PubMed ID: 1676940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-adrenoceptor antagonist, in dogs.
    Hino T; Sakai K; Ichihara K; Abiko Y
    Pharmacol Toxicol; 1989 Apr; 64(4):324-8. PubMed ID: 2568629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol inhibits accumulation of non-esterified fatty acids in the ischemic dog heart.
    Miura I; Hashizume H; Abiko Y
    Eur J Pharmacol; 1988 Aug; 152(3):281-8. PubMed ID: 3220107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
    Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
    Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
    J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs.
    Abiko Y; Gotoh H; Yokoyama T; Abiko T; Hashizume H; Akiyama K
    Arch Int Pharmacodyn Ther; 1994; 327(1):40-55. PubMed ID: 7944827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of nonesterified fatty acids in the dog myocardium during coronary artery occlusion determined by a method using 9-anthryldiazomethane.
    Miura I; Hashizume H; Akutsu H; Hara Y; Abiko Y
    Heart Vessels; 1987; 3(4):190-4. PubMed ID: 3453825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic action and protection of ischaemia myocardium after beta-blockade with bevantolol.
    Verdouw PD; Van Bremen RH; Verkeste CM; Van der Giessen WJ
    Eur J Pharmacol; 1985 May; 111(3):377-80. PubMed ID: 2862050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alleviation of myocardial ischaemia after administration of the cardioselective beta adrenoceptor antagonist bevantolol.
    Hartog JM; Verdouw PD
    Cardiovasc Res; 1986 Apr; 20(4):264-8. PubMed ID: 2872959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of trimetazidine on utilization of myocardial glycogen during coronary ligation in dogs.
    Sakai K; Fukushi Y; Abiko Y
    Pharmacology; 1986; 32(2):72-9. PubMed ID: 3952133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of lipids and lipid-intermediates in the heart during ischaemia.
    van der Vusse GJ; Prinzen FW; van Bilsen M; Engels W; Reneman RS
    Basic Res Cardiol; 1987; 82 Suppl 1():157-67. PubMed ID: 3311003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol on accumulation of NEFA in the ischemic perfused rat heart.
    Nakamura K; Ichihara K; Abiko Y
    Eur J Pharmacol; 1989 Jan; 160(1):61-9. PubMed ID: 2714364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial actions of bevantolol on subendocardial blood flow and contractile function in ischemic myocardium.
    Gross GJ; Buck JD; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1979; 1(1):139-47. PubMed ID: 94375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions.
    van der Vusse GJ; Roemen TH; Prinzen FW; Coumans WA; Reneman RS
    Circ Res; 1982 Apr; 50(4):538-46. PubMed ID: 7067061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile.
    Dukes ID; Vaughan Williams EM
    Br J Pharmacol; 1985 Feb; 84(2):365-80. PubMed ID: 2858236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation by isosorbide dinitrate of coronary occlusion-induced acidosis in the dog myocardium.
    Abiko Y; Fukushi Y; Haga N; Matsumura H
    Br J Pharmacol; 1986 Feb; 87(2):427-32. PubMed ID: 3955308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lidocaine on the accumulation of non-esterified fatty acids in the ischemic perfused rat heart.
    Nakamura K; Ichihara K; Abiko Y
    Eur J Pharmacol; 1989 Oct; 169(2-3):259-67. PubMed ID: 2806383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by atenolol of myocardial acidosis during ischemia in dogs: contribution of beta-1 adrenoceptors to myocardial acidosis.
    Sakai K; Abiko Y
    J Pharmacol Exp Ther; 1985 Mar; 232(3):810-6. PubMed ID: 2857788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601].
    Marchetti G; Merlo L; Noseda V
    Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial non-esterified fatty acids during normoxia and ischemia in Langendorff and working rat hearts.
    Nasa Y; Ichihara K; Abiko Y
    Jpn J Pharmacol; 1990 May; 53(1):129-33. PubMed ID: 2112658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.